Immuneering’s shares rocketed in premarket trading on Tuesday on the back of positive mid-stage data for its MEK inhibitor in pancreatic cancer, sparking plans to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
If the past is any indication, emergency departments and doctor’s offices are likely to see an influx of patients complaining of sensitive eyes, blurry vision,
A large-scale X chromosome-wide association study of Alzheimer’s disease identified SLC9A7 as a novel risk locus. (JAMA Neurology) Investigational fosgonimeton did not meet its primary
Cigna is moving to limit how much health insurance providers and employers have to pay for pricey and in-demand obesity medications. The insurer plans to